BackKindred Biosciences Overview

Kindred Biosciences Common Stock

Track Kindred Biosciences's common stock ($5K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$5000.00
↑ 25.00% YoYΔ $1000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Kindred Biosciences Common Stock History

Loading

Kindred Biosciences vs. peers: Common Stock Comparison

Loading

Kindred Biosciences Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Kindred Biosciences (KIN) FAQ

As of the most recent data (June 2021), KIN shows a common stock of $5K. That compares with $4K in the prior-year period — up 25.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KIN's common stock is now $5K (was $4K) — a 25.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kindred Biosciences is outperforming or lagging.

Tracking KIN's common stock over time shows whether Kindred Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $5K That compares with $4K in the prior-year period — up 25.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Kindred Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $5K) with ownership activity and broader fundamentals.

Kindred Biosciences's common stock is $5K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.